Medicinal Products

Tecentriq

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Tecentriq
Active Substance atezolizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC32
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for patients / caregivers
Kartica za bolesnika, verzija 5

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od teških kožnih reakcija uz primjenu lijeka Tecentriq (atezolizumab) 25.03.2021 Roche Registration GmbH
Pismo zdravstvenim radnicima o ograničenju indikacije lijeka Tecentriq (atezolizumab) 10.07.2018 Roche Registration GmbH
Back